With effect from 2015 all the annual financial statements of the Leriva companies are prepared in accordance with the Greek Accounting Standards (Law 4308/2014) which incorporates the provisions of European Directive 2013/34/EU on annual financial statements. For prior years the annual financial statements of the Group’s companies were prepared under Greek GAAP ("GAAP") and the accounting provisions of Law 2190/1920.
Adversely impacted by the Covid-19 pandemic, for the year ended December 31, 2020, consolidated sales of €14.987,262 fell 4.7% lower than the 2019 level of €15.720.988. This sales decline resulted in a decrease in Net Income which at €377.367 represented only 2.5% of sales and was significantly lower than the prior year figure of €975.448.
The annual financial statements of each of the Leriva legal entities can be accessed by clicking on the links below..
Leriva Holdings SA
Leriva SA
Leriva Diagnostics SA
Leriva Pharma SA (formerly Leriva Imaging SA)
Adversely impacted by the Covid-19 pandemic, for the year ended December 31, 2020, consolidated sales of €14.987,262 fell 4.7% lower than the 2019 level of €15.720.988. This sales decline resulted in a decrease in Net Income which at €377.367 represented only 2.5% of sales and was significantly lower than the prior year figure of €975.448.
The annual financial statements of each of the Leriva legal entities can be accessed by clicking on the links below..
Leriva Holdings SA
Leriva SA
Leriva Diagnostics SA
Leriva Pharma SA (formerly Leriva Imaging SA)
